A simple and accurate LC-MS/MS method for monitoring cyclosporin A that is suitable for high throughput analysis

被引:2
作者
Yuan, Ying-Shi [1 ,2 ]
Liao, Jia-Min [1 ,2 ]
Kang, Chun-Min [1 ,2 ]
Li, Bing-Ling [3 ,4 ]
Lei, Xu-Ri [1 ]
Yu, Ke-Wei [1 ,2 ]
Chen, Lu [1 ,2 ]
Dong, Heng [3 ,4 ]
Ke, Pei-Feng [1 ,2 ]
Xiao, Yao [1 ]
Huang, Xian-Zhang [1 ,2 ,6 ]
Zhao, Bei-Bei [3 ,4 ,5 ]
机构
[1] Guangzhou Univ Chinese Med, Clin Coll 2, Dept Lab Med, Guangzhou 510120, Guangdong, Peoples R China
[2] Guangdong Prov Hosp Chinese Med, Dept Lab Med, Guangzhou 510120, Guangdong, Peoples R China
[3] Guangzhou KingMed Ctr Clin Lab Co Ltd, Guangzhou 510120, Guangdong, Peoples R China
[4] Guangzhou Med Univ, KingMed Coll Lab Med, Guangzhou 510120, Guangdong, Peoples R China
[5] Guangzhou Med Univ, Guangzhou KingMed Ctr Clin Lab Co Ltd, KingMed Coll Lab Med, 3 Bioisl Luoxuan Rd, Guangzhou 510120, Guangdong, Peoples R China
[6] Guangzhou Univ Chinese Med, Dept Lab Med, Clin Coll 2, 111 Dade Rd, Guangzhou 510120, Guangdong, Peoples R China
关键词
cyclosporin A; LC-MS; MS; throughput; mass specimen; clinical application; TANDEM MASS-SPECTROMETRY; WHOLE-BLOOD; ANALYTICAL PERFORMANCE; TRANSPLANT RECIPIENTS; INTERNAL STANDARDS; TACROLIMUS; PHARMACOKINETICS; IMMUNOASSAYS; VALIDATION; EXPRESSION;
D O I
10.3892/etm.2023.12041
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
With time, the number of samples in clinical laboratories from therapeutic drug monitoring has increased. Existing analytical methods for blood cyclosporin A (CSA) monitoring, such as high-performance liquid chromatography (HPLC) and immunoassays, have limitations including cross-reactivity, time consumption, and the complicated procedures involved. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has long been considered the reference standard owing to its high accuracy, specificity, and sensitivity. However, large numbers of blood samples, multi-step preparation procedures, and longer analytical times (2.5-20 min) are required as a consequence of the different technical strategies, to ensure good analytical performance and routine quality assurance. A stable, reliable, and high throughput detection method will save personnel time and reduce laboratory costs. Therefore, a high throughput and simple LC-MS/MS method was developed and validated for the detection of whole-blood CSA with CSA-d12 as the internal standard in the present study. Whole blood samples were prepared through a modified one-step protein precipitation method. A C18 column (50x2.1 mm, 2.7 & mu;m) with a mobile phase flow rate of 0.5 ml/min was used for chromatographic separation with a total running time of 4.3 min to avoid the matrix effect. To protect the mass spectrometer, only part of the sample after LC separation was allowed to enter the mass spectrum, using two HPLC systems coupled to one mass spectrometry. In this way, throughput was improved with detection of two samples possible within 4.3 min using a shorter analytical time for each sample of 2.15 min. This modified LC-MS/MS method showed excellent analytical performance and demonstrated less matrix effect and a wide linear range. The design of multi-LC systems coupled with one mass spectrometry may play a notable role in the improvement of daily detection throughput, speeding up LC-MS/MS, and allowing it to be an integral part of continuous diagnostics in the near future.
引用
收藏
页数:13
相关论文
共 36 条
[1]   Potential interactions between uraemic toxins and drugs: an application in kidney transplant recipients treated with calcineurin inhibitors [J].
Andre, Camille ;
Choukroun, Gabriel ;
Bennis, Youssef ;
Kamel, Said ;
Lemaire-Hurtel, Anne Sophie ;
Masmoudi, Kamel ;
Bodeau, Sandra ;
Liabeuf, Sophie .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (11) :2284-2292
[2]   Comparison of LC-MS/MS and chemiluminescent immunoassays for immunosuppressive drugs reveals organ dependent variation in blood cyclosporine a concentrations [J].
Becker, Anna ;
Backman, Janne T. ;
Itkonen, Outi .
CLINICA CHIMICA ACTA, 2020, 508 :22-27
[3]  
Bjergum MW, 2019, METHODS MOL BIOL, V1872, P111, DOI 10.1007/978-1-4939-8823-5_11
[4]   Analytical performance of the CEDIA® cyclosporine PLUS whole blood immunoassay [J].
Butch, AW ;
Fukuchi, AM .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2004, 28 (03) :204-210
[5]   The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review [J].
Chighizola, Cecilia Beatrice ;
Ong, Voon H. ;
Meroni, Pier Luigi .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2017, 52 (03) :401-423
[6]  
Clinical and Laboratory Standards Institute, 2022, CLSI Document C62-AS, V2nd ed.
[7]   Validation of routine analytical method for injectable cyclosporine preparation control using HPLC-FIA assay [J].
Drira, C. ;
Ben Ayed, W. ;
Soussi, M. A. ;
Khrouf, M. Razgallah ;
Fradi, I .
ANNALES PHARMACEUTIQUES FRANCAISES, 2021, 79 (03) :266-274
[8]   A high-throughput LC-MS/MS method for the quantification of four immunosu- ppressants drugs in whole blood [J].
Gong, Zi-Shan ;
Wu, Zhong-Hao ;
Xu, Shu-Xin ;
Han, Wen-Nian ;
Jiang, Xiao-Mei ;
Liu, Hai -Pei ;
Yan-Li ;
Wei-Hu ;
Yan-Wang .
CLINICA CHIMICA ACTA, 2019, 498 :21-26
[9]   Patients with adult minimal change nephrotic syndrome treated with long-term cyclosporine did not experience a reduction in their eGFR [J].
Inoue, Makoto ;
Yumura, Wako ;
Morishita, Yoshiyuki ;
Ito, Chiharu ;
Hamano, Yoshiaki ;
Ando, Yasuhiro ;
Muto, Shigeaki ;
Kusano, Eiji .
CLINICAL NEPHROLOGY, 2013, 79 (02) :101-106
[10]   KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword [J].
Wheeler, David C. ;
Winkelmayer, Wolfgang C. .
KIDNEY INTERNATIONAL SUPPLEMENTS, 2017, 7 (01) :12-12